Overall, these data provide examples of changes in CYP expression and metabolism of PUFAs and subsequent production of oxylipins that are consistent with perturbations in energy metabolism, lipid metabolism, lipid distribution, metabolic disease, and obesity. The gene discussed is PPIG; the disease is obesity disorder.